A detailed history of National Bank Of Canada transactions in Vaxart, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 6,200 shares of VXRT stock, worth $3,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,200
Previous 6,200 -0.0%
Holding current value
$3,595
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.58 - $0.99 $3,595 - $6,138
6,200 New
6,200 $5,000
Q2 2022

Jul 28, 2022

SELL
$2.7 - $5.28 $542 - $1,061
-201 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$4.29 - $6.64 $1.36 Million - $2.1 Million
-316,000 Reduced 99.94%
201 $1,000
Q4 2021

Jan 24, 2022

BUY
$5.77 - $7.96 $1.82 Million - $2.52 Million
316,201 New
316,201 $1.98 Million

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.